Comment on ‘The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials’-Reference-Cited by-同舟云学术

Comment on ‘The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials’

Published:2024-05-22 Issue:9 Volume:110 Page:5907-5909
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Zhang Xiaochen¹,Ren Yu²,Luo Hua³

Affiliation:

1. Department of Psychiatry, Taizhou Second People’s Hospital

2. Department of Pharmacy, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

3. Department of Orthopedic, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, People’s Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials;Meng;Int J Surg,2023

2. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty;Westrich;J Arthroplasty,2006

3. Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study;Zhou;BMC Musculoskelet Disord,2023

4. [Comparative study between enoxaparin and salicylic acetyl acid in antithrombotic prophylaxis for patients undergoing total knee arthroplasty];Cortes-De la Fuente;Acta Ortop Mex,2021

5. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial;Sidhu;JAMA-J Am Med Assoc,2022